Skip to main content
Premium Trial:

Request an Annual Quote

$500K Gift to Progress Kimmel Cancer Center Test for Ovarian, Endometrial Cancers

NEW YORK (GenomeWeb News) – An anonymous donor has provided $500,000 to the Johns Hopkins Kimmel Cancer Center to advance its genomics-based screening test for ovarian and endometrial cancers, the cancer center announced on Thursday.

The sequencing-based test, called PapGene was developed by researchers at the Kimmel Center, and the gift will be used to conduct large-scale clinical trials and laboratory research on the test.

PapGene uses cervical fluid to detect cancer-specific mutations that result in ovarian and endometrial cancers. The test uses the same liquid samples collected during many modern-day Papanicolaou, or "Pap," tests for cervical abnormalities and human papillomavirus infection. While the Pap test has widely been used to screen for cervical cancer, no such test is available for ovarian and endometrial cancers, the center noted.

Lead investigator Luis Diaz said in a statement, "With this support, we are able to move this research from the laboratory to clinical trials more quickly."

Swim Across America provided funding for the initial research.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more